SOLICITATION NOTICE
65 -- OPTICAL COHERENCE TOMOGRAPHER
- Notice Date
- 2/17/2009
- Notice Type
- Presolicitation
- NAICS
- 333314
— Optical Instrument and Lens Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMLC, 1681 Nelson St, FT Detrick, Maryland, 21702-9203
- ZIP Code
- 21702-9203
- Solicitation Number
- N6264509RCES080
- Archive Date
- 3/12/2009
- Point of Contact
- Erin M Cotter, Phone: 301-619-1086, Burzie C Baker III,, Phone: 301-619-0707
- E-Mail Address
-
erin.cotter@med.navy.mil, burzie.baker@med.navy.mil
- Small Business Set-Aside
- N/A
- Description
- DEPARTMENT OF THE NAVY, NAVAL MEDICAL LOGISTICS COMMAND SYNOPSIS AND SOLICITATION The Naval Medical Logistics Command intends to negotiate on a sole source basis (IAW FAR 13.501) with Carl Zeiss Meditec, 5160 Hacienda Drive, Dublin, CA 94568, as the only responsible source that can provide an optical coherence tomographer (OCT) that is compatible with the currently installed base of ophthalmic equipment at the requesting facilities. The requirement is for two optical coherence tomographers, one for Naval Hospital Corpus Christi and one for Naval Medical Center Portsmouth. The systems shall be capable of two-dimensional, digital imaging and measurement of the retinal nerve fiber layer, retina, sub-retinal space and intra-ocular pathology. The systems shall have the ability to measure the thickness of the retinal nerve fiber layer and to image the macula in multiple cross sections. The systems shall be compatible with the previous base of Carl Zeiss ophthalmic measurement equipment to ensure a standard method of measurement for the proper clinical evaluation of patients. The electrical requirements are 120 VAC, 60Hz. Regulatory Requirements: The system and all of the components, shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. This acquisition is being conducted under simplified acquisition procedures FAR 13.501 under the authority of the test program for commercial items (section 4202 of the Clinger-Cohen Act of 1996). There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 333314. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to erin.cotter@med.navy.mil. No phone calls accepted.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=06badad2eb463564e93ebd6de50633ad&tab=core&_cview=1)
- Place of Performance
- Address: NAVAL HOSPITAL CORPUS CHRISTI, TX and NAVAL MEDICAL CENTER PORTSMOUTH, VA, CORPUS CHRISTI, Texas, United States
- Record
- SN01751575-W 20090219/090217215914-06badad2eb463564e93ebd6de50633ad (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |